• Search
  • Chat
  • News
  • Discover
  • Portfolio
  • Insights
  • Solutions
  • Disclaimer
  • Contact
  • Sign In
  • New chat
  • Sign up to save conversations
    NAN.AX logo
    Nanosonics Limited
    flag
    NAN
    3.96
    AUD
    -0.38-9.60%
    $1.20BMarket Cap
    Health CareSector
    Health Care SuppliesIndustry
    PE ratio (TTM)63.73
    Dividend yield (%)N/A
    Beta (1Y)1.75
    Consensus RatingHold
    News
    SectorHealth Care
    IndustryHealth Care Supplies
    Websitenanosonics.com.au
    CEOMichael C. Kavanagh
    Description

    Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

    DividendsThis company has not previously paid any dividends.

    Financial information provided by Financial Modelling Prep. Logos provided by Logo.dev.

    Latest News
    Dec 9, 2025
    positive

    Nanosonics Limited has provided an update on its ongoing on-market buy-back program. As of 9 December 2025, the company has repurchased a total number of shares.

    Market Index - S&P/ASX 300 - Intelligent InvestorMarket Index - S&P/ASX 200 - Intelligent InvestorNanosonics Limited Updates on Market Buy-Back Program
    flag
    ^AXJO
    1.23%